PRLD - Balance Sheet - Prelude Therapeutics Incorporated

Current Liabilities	25.6 M
Accounts Payable	7.73 M
Short-Term Debt	2.7 M
Other Current Liabilities	15.2 M
Non-Current Liabilities	18.4 M
Long-Term Debt	0
Other Non-Current Liabilities	18.4 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	12.5	25.3	30.6	31.8	218.3	18.9	15.6
Short Term Investments	121.1	207.6	171.1	259.4	0	0	0
Receivables	0	0	0	0	0	0	0
Inventory	0	0	0	0	0	0	0
Other Current Assets	2.3	2.7	2.7	7.8	5.0	1.3	0
Total Current Assets	135.9	235.6	204.4	295.1	220.8	20.2	15.6
PP&E	35.5	37.7	6.7	5.6	2.5	1.6	0.8
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	4.0	4.0	0	0	0
Other Long Term Assets	4.2	4.3	5.4	0.3	0.3	0	0
Other Assets	0	0	0	0	0	0	0
Total Assets	175.5	277.7	220.5	305.1	223.6	21.9	16.4
LIABILITIES
Accounts Payable	7.7	4.6	6.8	7.8	3.9	2.0	1.4
Short Term Debt	2.7	1.5	3.7	3.5	0	0.3	0
Other Current Liabilities	15.2	15.8	11.3	7.9	7.5	2.6	1.1
Total Current Liabilities	25.6	21.8	21.7	19.2	11.4	4.8	2.4
Long Term Debt	0	15.4	0	0	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0
Other Liabilities	18.4	3.3	3.4	0	32 K	66.4	36.7
Total Liabilities	44.1	40.6	25.1	19.2	11.4	71.3	39.1
EQUITY
Common Stock	4 K	5 K	5 K	5 K	4 K	0	0
Retained Earnings	(583.6)	(456.4)	(334.6)	(219.1)	(107.4)	(50.5)	(22.9)
Other Accumulative Comprehensive Income/Loss	35 K	0.2	(1.7)	(0.7)	(223.6)	0	(0.2)
Total Equity	131.5	237.1	195.4	285.9	212.2	(49.4)	(22.7)
Total Liabilities and Equity	175.5	277.7	220.5	305.1	223.6	21.9	16.4
SHARES OUTSTANDING
Common Shares Outstanding	75.8	60.4	47.4	47.6	43.7	32.4	32.1

Free